TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company pioneering innovative therapies that target the tumor microenvironment (TME) in cancer treatment, has formally announced the convocation of its…
The World Health Organization (WHO) has raised an urgent alarm over the impact of funding shortfalls on global health access, revealing that at least 70 countries are currently experiencing disruptions…
Global: Pfizer Strikes $6 Billion Licensing Deal with China’s 3SBio, Boosts Global Oncology Pipeline
Pfizer Inc. has entered into a strategic agreement with China-based biopharmaceutical company 3SBio Inc., licensing a promising cancer drug candidate and reinforcing its oncology portfolio amid increasing global demand for…
Qure.AI, a leading India-based healthtech startup specialising in artificial intelligence solutions for medical diagnostics, has outlined plans to become profitable by the next financial year and is targeting a public…
Leading pharmaceutical companies are pushing back against U.S. President Donald Trump’s proposed global drug tariffs, warning that an abrupt implementation could disrupt medical supply chains, escalate compliance costs, and limit…
In a major advancement for rare disease treatment and regulatory medicine, the U.S. Food and Drug Administration (FDA) has approved the expanded use of Amgen’s Uplizna (inebilizumab) as the first…
In a significant development within the pharmaceutical regulatory landscape, GlaxoSmithKline (GSK) and Pfizer have agreed to end a high-profile legal dispute involving patent infringement claims tied to their respiratory syncytial…
The European Medicines Agency (EMA) has initiated a review of GlaxoSmithKline’s (GSK.L) request to expand the use of its asthma drug Nucala (mepolizumab) as an additional treatment for chronic obstructive…
On World Tuberculosis (TB) Day, the World Health Organization (WHO) has issued a dire warning, emphasizing the urgent need for increased investment in TB care. The organization lamented that severe…